Skip to Main Content
Yale School of Medicine
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Yale School of Medicine
/
Internal Medicine
/
Medical Oncology
MENU
Yale School of Medicine
MENU
Medical Oncology
About Us
Message from the Chief
Business Office
Fellowship
Covid-19 Collaborative Group
Faculty
Patient Care
Research
Translational Research
Clinical Trials
YSM Home
INFORMATION FOR
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Popular Links
Search
32 results
Refine
People (19360)
Web Pages (12542)
Documents (6941)
News (53326)
Events (27732)
Media (2887)
Clinical Trials (644)
Gender
Male (2)
Female (2)
Accept Healthy Volunteers
Yes (0)
No (3)
Categories
Addictive Behavior (0)
Aging (0)
Alcohol Addiction (0)
Alzheimer's (0)
Arthritis (0)
Asthma (0)
Autism (0)
Blood Disorders (0)
Brain & Spinal Cord & Nervous System (0)
Cancer (32)
Bladder (0)
Brain (0)
Breast (4)
Colorectal (3)
Gynecological (3)
Head and Neck (1)
Kidney (0)
Leukemia (1)
Liver (1)
Lung (8)
Lymphoma (2)
Melanoma (1)
Myeloma (4)
Non-Therapeutic (0)
Other Cancers (0)
Pancreas (4)
Pediatric Cancers (0)
Phase 1 (1)
Prevention (0)
Prostate (2)
Sarcoma (0)
Stomach and Esophagus (0)
Supportive Care (0)
Thyroid (2)
Children Health (0)
COVID-19 (0)
Diabetes (0)
Digestive System (0)
Diseases of the Respiratory Systems (0)
Endocrine System (0)
Genetics (0)
Headaches (0)
Hearing/Ear (0)
Heart/Cardiovascular (0)
Hepatitis (0)
HIV/AIDS (0)
Immune System (0)
Infants & Newborns (0)
Infectious Disease (0)
Kidney & Urinary Tract (0)
Liver (0)
Lung (0)
Men Health (0)
Mental Health & Behavioral Research (0)
Muscle & Bone (0)
Obesity & Weight Management (0)
Pain Control (0)
Poisoning/Injury (0)
Pregnancy and Obstetrics (0)
Sickle Cell (0)
Skin/Dermatology (0)
Sleep Disorders (0)
Tobacco Addiction (0)
Vision/Eye (0)
Women Health (0)
Status
New (0)
IRB Initial Approval (0)
PRC Approval (0)
Project Manager Signoff (0)
Open to Accrual (32)
Closed to Accrual (0)
For Affiliates Only (0)
IRB Study Closure (0)
Age
Select a year
Select a year
Less than 1 year
1 year
2 years
3 years
4 years
5 years
6 years
7 years
8 years
9 years
10 years
11 years
12 years
13 years
14 years
15 years
16 years
17 years
18 years
19 years
20 years
21 years
22 years
23 years
24 years
25 years
26 years
27 years
28 years
29 years
30 years
31 years
32 years
33 years
34 years
35 years
36 years
37 years
38 years
39 years
40 years
41 years
42 years
43 years
44 years
45 years
46 years
47 years
48 years
49 years
50 years
51 years
52 years
53 years
54 years
55 years
56 years
57 years
58 years
59 years
60 years
61 years
62 years
63 years
64 years
65 years
66 years
67 years
68 years
69 years
70 years
71 years
72 years
73 years
74 years
75 years
76 years
77 years
78 years
79 years
80 years
81 years
82 years
83 years
84 years
85 years
86 years
87 years
88 years
89 years
90 years
Search
Profile
Jeremy Kortmansky
Clear
Search
Showing 32 results
in 'Clinical Trials'
Clinical Trials
Open to Accrual
Jeremy Kortmansky
Clinical Trial
A Phase 1 First-in Human, Multi-Center, Open Label Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination With ABBV-181 in Subjects With Locally Advanced or Metastatic Solid Tumors
Both / 18+ years
Clinical Trial
A Phase 2 Trial to Evaluate the Safety and Efficacy of Combination Therapies in Patients With Advanced Upper Gastrointestinal Tract Malignancies (EDGE-Gastric)
Clinical Trial
A Phase II Evaluation of Afatinib
Female / Up to 18 years
Clinical Trial
A Phase II Evaluation of Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-drug Conjugate, in Patients With Persistent or Recurrent Endometrial Carcinoma
Clinical Trial
A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers
Clinical Trial
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Clinical Trial
A Prospective, Observational Study of Real-World Efficacy and Patient-Reported Quality of Life
Clinical Trial
A Randomized Phase II Trial Of Circulating Tumor DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer
Clinical Trial
A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
Clinical Trial
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Clinical Trial
An Open-Label Phase II Trial to Evaluate the Efficacy and Safety of Neoadjuvant Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel Plus Trastuzumab and Pertuzumab in Early Stage HER2-Negative Breast Cancer Patients Selected With a Test Measuring Live Cell HER2 Signaling Transduction (FACT 1)
Clinical Trial
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Clinical Trial
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Clinical Trial
Determining Mechanisms of Sensitivity and Resistance to Anti-Cancer Therapy for Advanced Lung Cancer
Clinical Trial
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Clinical Trial
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Clinical Trial
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Clinical Trial
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Clinical Trial
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
Clinical Trial
Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Selected Solid Tumors
Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads
[7640,9243,2243,2317,8261,8480,8766,2324,3053]
{"namedChunks":["modules-page-components-ComponentWrapper","modules-search-components-global-search-GlobalSearchContainer","modules-footer-components-Footer"]}